Mika Mizuno

2.7k total citations
77 papers, 1.2k citations indexed

About

Mika Mizuno is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Surgery. According to data from OpenAlex, Mika Mizuno has authored 77 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Obstetrics and Gynecology, 43 papers in Reproductive Medicine and 19 papers in Surgery. Recurrent topics in Mika Mizuno's work include Endometrial and Cervical Cancer Treatments (44 papers), Ovarian cancer diagnosis and treatment (37 papers) and Uterine Myomas and Treatments (16 papers). Mika Mizuno is often cited by papers focused on Endometrial and Cervical Cancer Treatments (44 papers), Ovarian cancer diagnosis and treatment (37 papers) and Uterine Myomas and Treatments (16 papers). Mika Mizuno collaborates with scholars based in Japan, United States and Greece. Mika Mizuno's co-authors include Fumitaka Kikkawa, Hiroaki Kajiyama, Kiyosumi Shibata, Michiyasu Kawai, Tetsuro Nagasaka, Shiro Suzuki, Tomokazu Umezu, Toru Nakanishi, Eiko Yamamoto and Kazuhiko Ino and has published in prestigious journals such as Journal of Clinical Oncology, American Journal of Obstetrics and Gynecology and British Journal of Cancer.

In The Last Decade

Mika Mizuno

71 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mika Mizuno Japan 23 612 488 275 225 201 77 1.2k
Annalisa Garbi Italy 16 565 0.9× 346 0.7× 251 0.9× 247 1.1× 158 0.8× 37 1.0k
Masamichi Hiura Japan 16 705 1.2× 750 1.5× 198 0.7× 251 1.1× 184 0.9× 50 1.2k
Annika Auranen Finland 23 930 1.5× 492 1.0× 316 1.1× 385 1.7× 376 1.9× 72 1.6k
Arto Leminen Finland 23 628 1.0× 270 0.6× 249 0.9× 304 1.4× 348 1.7× 38 1.2k
Abbie L. Fields United States 19 454 0.7× 488 1.0× 318 1.2× 325 1.4× 272 1.4× 43 1.2k
Jamal Rahaman United States 18 571 0.9× 522 1.1× 163 0.6× 252 1.1× 315 1.6× 52 1.3k
Hidekatsu Nakai Japan 21 667 1.1× 418 0.9× 445 1.6× 191 0.8× 323 1.6× 75 1.3k
Susan Zweizig United States 15 429 0.7× 397 0.8× 196 0.7× 190 0.8× 155 0.8× 32 925
Joanne Rutgers United States 23 555 0.9× 848 1.7× 391 1.4× 341 1.5× 381 1.9× 53 1.8k
Michiyasu Kawai Japan 26 1.4k 2.3× 821 1.7× 221 0.8× 674 3.0× 278 1.4× 88 2.0k

Countries citing papers authored by Mika Mizuno

Since Specialization
Citations

This map shows the geographic impact of Mika Mizuno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mika Mizuno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mika Mizuno more than expected).

Fields of papers citing papers by Mika Mizuno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mika Mizuno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mika Mizuno. The network helps show where Mika Mizuno may publish in the future.

Co-authorship network of co-authors of Mika Mizuno

This figure shows the co-authorship network connecting the top 25 collaborators of Mika Mizuno. A scholar is included among the top collaborators of Mika Mizuno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mika Mizuno. Mika Mizuno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Togami, Shinichi, et al.. (2024). Long-term outcomes of sentinel lymph node navigation surgery for early-stage cervical cancer. International Journal of Clinical Oncology. 29(11). 1740–1745. 1 indexed citations
4.
Mizuno, Mika, et al.. (2024). The Utility of an Human Papillomavirus Genotype Assay for Cancer Screening in Self-Collected Urine and Vaginal Samples from Japanese Women. Gynecologic and Obstetric Investigation. 90(2). 1–10. 1 indexed citations
5.
Yanazume, Shintaro, Yusuke Kobayashi, Toshiaki Akahane, et al.. (2024). Can Endometrial Cytology Identify Patients Who Would Benefit from Immunotherapy?. Acta Cytologica. 68(2). 128–136. 2 indexed citations
6.
Togami, Shinichi, et al.. (2023). The first report of surgery for gynecological diseases using the hinotori™ surgical robot system. Japanese Journal of Clinical Oncology. 53(11). 1034–1037. 26 indexed citations
7.
Togami, Shinichi, Mika Fukuda, Mika Mizuno, Shintaro Yanazume, & Hiroaki Kobayashi. (2023). Efficacy and prognosis of robotic surgery with sentinel node navigation surgery in endometrial cancer. Journal of Gynecologic Oncology. 34(6). e68–e68. 7 indexed citations
8.
Yanazume, Shintaro, Yusuke Kobayashi, Toshiaki Akahane, et al.. (2023). Cytopathological features associated with POLE mutation in endometrial cancer. Cytopathology. 34(3). 211–218. 7 indexed citations
9.
Yanazume, Shintaro, et al.. (2022). Metastatic Leiomyoma Following Menopause: A Case Report and Review of Literature. Cureus. 14(11). e31549–e31549.
10.
Nomura, Hiroyuki, Daisuke Aoki, Nobuyuki Susumu, et al.. (2019). Analysis of the relapse patterns and risk factors of endometrial cancer following postoperative adjuvant chemotherapy in a phase III randomized clinical trial. Gynecologic Oncology. 155(3). 413–419. 7 indexed citations
11.
Matoda, Maki, Nobuhiro Takeshima, Hirofumi Michimae, et al.. (2018). Postoperative chemotherapy for node-positive cervical cancer: Results of a multicenter phase II trial (JGOG1067). Gynecologic Oncology. 149(3). 513–519. 28 indexed citations
12.
Shimokawa, Mototsugu, Toshinobu Hayashi, Takahiro Kogawa, et al.. (2018). Evaluation of Combination Antiemetic Therapy on CINV in Patients With Gynecologic Cancer Receiving TC Chemotherapy. Anticancer Research. 39(1). 225–230. 8 indexed citations
13.
Hosono, Satoyo, Hidemi Ito, Isao Oze, et al.. (2017). Improvement in 5-Year Relative Survival in Cancer of the Corpus Uteri From 1993–2000 to 2001–2006 in Japan. Journal of Epidemiology. 28(2). 75–80. 5 indexed citations
14.
Ishikawa, Mitsuya, Takahiro Kasamatsu, Hitoshi Tsuda, et al.. (2017). Prognostic factors and optimal therapy for stages I–II neuroendocrine carcinomas of the uterine cervix: A multi-center retrospective study. Gynecologic Oncology. 148(1). 139–146. 47 indexed citations
15.
Kajiyama, Hiroaki, Mika Mizuno, Kiyosumi Shibata, et al.. (2014). Oncologic outcome after recurrence in patients with stage I epithelial ovarian cancer: are clear-cell and mucinous histological types a different entities?. European Journal of Obstetrics & Gynecology and Reproductive Biology. 181. 305–310. 4 indexed citations
16.
Mitsui, Hiroko, Kiyosumi Shibata, Yukio Mano, et al.. (2013). The expression and characterization of endoglin in uterine leiomyosarcoma. Clinical & Experimental Metastasis. 30(6). 731–740. 4 indexed citations
17.
Mizuno, Mika, Hiroaki Kajiyama, Kiyosumi Shibata, et al.. (2012). Adjuvant Chemotherapy for Stage I Ovarian Clear Cell Carcinoma. International Journal of Gynecological Cancer. 22(7). 1143–1149. 28 indexed citations
18.
Mitsui, Hiroko, Kiyosumi Shibata, Shiro Suzuki, et al.. (2011). Functional interaction between peritoneal mesothelial cells and stem cells of ovarian yolk sac tumor (SC-OYST) in peritoneal dissemination. Gynecologic Oncology. 124(2). 303–310. 18 indexed citations
19.
Kajiyama, Hiroaki, Kiyosumi Shibata, Mika Mizuno, et al.. (2011). Long-term survival of young women receiving fertility-sparing surgery for ovarian cancer in comparison with those undergoing radical surgery. British Journal of Cancer. 105(9). 1288–1294. 52 indexed citations
20.
Niwa, Yoshimitsu, Hidemi Ito, Keitaro Matsuo, et al.. (2006). Lymphotoxin-α polymorphisms and the risk of endometrial cancer in Japanese subjects. Gynecologic Oncology. 104(3). 586–590. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Annalisa Garbi Breakdown of academic impact, for papers by Masamichi Hiura Breakdown of academic impact, for papers by Annika Auranen Breakdown of academic impact, for papers by Arto Leminen Breakdown of academic impact, for papers by Abbie L. Fields Breakdown of academic impact, for papers by Jamal Rahaman Breakdown of academic impact, for papers by Hidekatsu Nakai Breakdown of academic impact, for papers by Susan Zweizig Breakdown of academic impact, for papers by Joanne Rutgers Breakdown of academic impact, for papers by Michiyasu Kawai
Rankless by CCL
2026